Production (Stage)
C
Harmony Biosciences Holdings, Inc. HRMY
$35.42 -$0.18-0.51% NASDAQ
Recommendation
Prev Close
$35.60
Volume
403,104
Avg Vol (90D)
700,307
Market Cap
$2.04B
Dividend & Yield
--
52-Week Range
$26.47 - $41.61
P/E (TTM)
13.60
EPS (TTM)
$2.62
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory
6/9/2025 - Yahoo! Finance: News
Harmony Biosciences Holdings, Inc. (HRMY): A Bull Case Theory
6/9/2025 - Insider Monkey
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Acquired by Bridge City Capital LLC
6/9/2025 - MarketBeat
Harmony Biosciences Holdings (HRMY) Shares Cross Below 200 DMA
6/5/2025 - Market News Video
Harmony Biosciences Strengthens Patent Position With Favorable Settlement in ANDA Litigation
6/5/2025 - Business Wire
Financial Management Professionals Inc. Makes New $29,000 Investment in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
6/5/2025 - Ticker Report
Hennion & Walsh Asset Management Inc. Boosts Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
6/5/2025 - MarketBeat
Harmony Biosciences Holdings Inc (HRMY) to Participate in Goldman Sachs Healthcare Conference ...
6/4/2025 - GuruFocus
Harmony Biosciences Holdings (HRMY, $35.31) entered Downtrend as Momentum indicator drops below 0 level on Jun 03, 2025
6/4/2025 - Tickeron - Stocks
Harmony Biosciences to Participate in Goldman Sachs 46th Annual Global Healthcare Conference
6/4/2025 - Business Wire
Universal Beteiligungs und Servicegesellschaft mbH Invests $3.24 Million in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
6/3/2025 - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Short Interest Update
6/2/2025 - MarketBeat
Oppenheimer Begins Coverage on Harmony Biosciences (NASDAQ:HRMY)
6/2/2025 - MarketBeat
Nuveen Asset Management LLC Buys 8,193 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/31/2025 - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Shares Bought by Two Sigma Advisers LP
5/28/2025 - MarketBeat
Bank of America Corp DE Decreases Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/28/2025 - MarketBeat
Ameriprise Financial Inc. Purchases 18,730 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/28/2025 - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Given Average Recommendation of "Buy" by Analysts
5/28/2025 - MarketBeat
Voloridge Investment Management LLC Grows Stock Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/26/2025 - MarketBeat
6,503 Shares in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Acquired by State of Wyoming
5/24/2025 - Ticker Report
Rafferty Asset Management LLC Takes $279,000 Position in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/24/2025 - Ticker Report
Harmony Biosciences Holdings (HRMY, $35.62) RSI Indicator left the overbought zone on May 20, 2025
5/21/2025 - Tickeron - Technical Analysis
Valor Management LLC Sells 4,600,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/20/2025 - Ticker Report
A Piece Of The Puzzle Missing From Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) 26% Share Price Climb
5/20/2025 - Simply Wall St
Nomura Holdings Inc. Has $1.81 Million Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY)
5/20/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$744.85M
EBITDA (TTM)
$218.99M
EBIT (TTM)
$195.04M
Net Income (TTM)
$152.72M
Balance Sheet
Total Assets (Q)
$1.06B
Total Debt (Q)
$177.46M
Total Liabilities (Q)
$335.01M
Book Value Per Share (Q)
$12.55
Cash Flow
Cash from Operations (TTM)
$222.67M
Cash from Investing (TTM)
-$58.94M
Cash from Financing (TTM)
-$7.71M
Net Change in Cash (TTM)
$156.02M
Filings
Filing Date
Tuesday, May 6, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
1.77
7-Day Total Return
4.02%
30-Day Total Return
19.62%
60-Day Total Return
8.25%
90-Day Total Return
-8.76%
Year to Date Total Return
1.69%
1-Year Total Return
16.13%
2-Year Total Return
-2.80%
3-Year Total Return
-22.15%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $26.47
52-week High
Oct 29, 2024 - $41.61
Valuation
Market Cap
$2.04B - Mid Cap
Enterprise Value
$1.71B
Price/Sales (TTM)
2.80
Price/Book (Q)
2.84
Dividends and Shares
Shares Outstanding
58.52M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.harmonybiosciences.com
Phone Number
484 539 9800
Address
630 West Germantown Pike
Plymouth Meeting, PA 19462
Country
United States
Year Founded
2017
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the... more
NASDAQ 06/09/2025 4:00PM Eastern Quotes delayed